Drug Conjugation Technology definition

Drug Conjugation Technology means (a) methods that are useful in attaching the [***] or [***] to antibodies using the linker [***] or [***], including the composition and methods of making and using such cytotoxic compound [***] or [***] and (b) any related assays and methods SGI provided to Genmab pursuant to the Research Program or provides to Genmab pursuant to Section 4.4 or the Collaboration Program, in each case to the extent Controlled by SGI.
Sample 1Sample 2
Drug Conjugation Technology means chemical compositions and methods that are useful to attach cytotoxins or cytostatic compounds to Antibodies, including the composition and methods of making and using cytotoxic or cytostatic compounds, as well as compositions and methods useful for attaching the foregoing cytotoxic or cytostatic compounds to Antibodies.
Sample 1Sample 2Sample 3
Drug Conjugation Technology means drug conjugation chemistry owned or controlled by SGI, [*] and linker technology for attaching drugs to Antibodies that is the subject matter of the Licensed Patents and SGI Know-How.
Sample 1

Examples of Drug Conjugation Technology in a sentence

  • SGI shall, in all cases, prepare, own and be responsible for the section of the applicable DMF that describes the Drug Conjugation Technology.

  • Confidential Information of SGI shall include SGI Know-How, Drug Conjugation Technology, SGI’s interest in any Program Inventions, whether or not marked “Confidential.” Confidential Information of Genmab shall include Genmab Technology, the contents, terms and conditions of Genmab’s In-Licenses, and Genmab’s interest in any Program Inventions, whether or not marked “Confidential”.

  • The research license granted to EOS under this Section 2.2 shall not include (i) the right to use SGI Technology for any commercial purpose whatsoever, (ii) the right to grant sublicenses thereto to any Affiliate or Third-Party, (iii) the right to initiate any human clinical trial in any country, or (iv) the right to make, have made, use or sell a Product or the Drug Conjugation Technology for any purpose other than the foregoing evaluation, including for any commercial purpose.

  • SGI shall disclose to EOS such Drug Conjugation Technology, SGI Know-How, New Technologies and Improvements as is necessary to enable EOS to use the Drug Conjugation Technology, SGI Know-How, New Technologies and Improvements at its own facilities on the terms and subject to the conditions of this Agreement.

  • The terms of this Agreement and Information related directly to the Product shall be the Confidential Information of both Parties; provided, that Drug Conjugation Technology (as such term is defined in the Collaboration Agreement) will be Confidential Information of SGI.


More Definitions of Drug Conjugation Technology

Drug Conjugation Technology means drug conjugation chemistry owned or controlled by SGI, including [***] and linker technology for attaching drugs to Antibodies that is the subject matter of the Licensed Patents and SGI Know-How.
Sample 1Sample 2
Drug Conjugation Technology means (a) [***] compounds such as [***] and [***] and certain [***] and [***] thereof, and methods of making and using such [***] compounds (b) compositions and methods useful for attaching the foregoing [***] compounds to [***] and (c) any related assays and methods SGI provides to Licensee pursuant to the Research Program.
Sample 1Sample 2
Drug Conjugation Technology means (a) cytotoxins or cytostatic
Sample 1Sample 2
Drug Conjugation Technology means chemical compositions and methods, including methods of manufacture, that are Controlled by SGI and that are useful to attach cytotoxins or cytostatic compounds to Antibodies, including the composition and methods of making and using cytotoxic or cytostatic compounds, as well as compositions and methods useful for attaching the foregoing cytotoxic or cytostatic compounds to Antibodies. “Effective Date” means the date set forth in the first line of this Agreement. “EMEA” means the European Medicines Agency and any successor agency(ies) thereto. “Events of Force Majeure” has the meaning set forth in Article 19. “Exclusive Antigen” means collectively, the First Exclusive Antigen, the Second Exclusive Antigen and the Third Exclusive Antigen, but specifically excluding any Collaboration Antigen. “Exclusive License” has the meaning set forth in Section 10.1.2. -9-
Sample 1
Drug Conjugation Technology means (a) cytotoxins or
Sample 1
Drug Conjugation Technology means (a) cytotoxins or cytostatic compounds
Sample 1
Drug Conjugation Technology means Drug Conjugation Materials and uses thereof, including [***], and methods for producing Drug Conjugation Materials and attaching Drug Conjugation Materials to [***] and the [***], and uses thereof.
Sample 1